1 | antibody | 7,307 |
2 | autoantibody | 179 |
3 | aptamer | 88 |
4 | antitoxin | 58 |
5 | antibody-based | 56 |
6 | alloantibody | 19 |
7 | kinome | 16 |
8 | tcd8 | 16 |
9 | edlf | 13 |
10 | paraprotein | 11 |
11 | immunotolerance | 9 |
12 | widal | 9 |
13 | anti-cocaine | 6 |
14 | attractant | 6 |
15 | sero | 6 |
16 | anti-hd | 5 |
17 | auto-antibody | 5 |
18 | clouse | 5 |
19 | ctlp | 5 |
20 | gp2a-iga | 5 |
21 | ige-antibody | 5 |
22 | igg-antibody | 5 |
23 | cane-derived | 4 |
24 | time-attenuation | 4 |
25 | ag/ab | 3 |
26 | anti-g | 3 |
27 | anti-hbsag | 3 |
28 | anti-tvlpg | 3 |
29 | epitope-associated | 3 |
30 | minivector | 3 |
31 | tg-dtg | 3 |
32 | aggregometric | 2 |
33 | aggresomal | 2 |
34 | anti-bodies | 2 |
35 | anti-capsid | 2 |
36 | anti-omp | 2 |
37 | bio-hythane | 2 |
38 | class/subclass | 2 |
39 | gammopathy-associated | 2 |
40 | hba1c-graphical | 2 |
41 | hemolysin-neutralizing | 2 |
42 | igg2c | 2 |
43 | intensity-time | 2 |
44 | neriifolin | 2 |
45 | ph-optima | 2 |
46 | piercing® | 2 |
47 | pro-/anti-oxidant | 2 |
48 | titters | 2 |
49 | -adrenoceptor-induced | 1 |
50 | -t2 | 1 |
51 | -versus-e | 1 |
52 | /interleukin-1-mediated | 1 |
53 | 2/antioxidant | 1 |
54 | 5-exo-tet | 1 |
55 | 7,12-dimethylbenzanthracene/12-o-tetradecanoyl-phorbol-13-acetate | 1 |
56 | antibodies-induced | 1 |
57 | antibodies.no | 1 |
58 | antibody-doxorubicin | 1 |
59 | antigens-unless | 1 |
60 | areas-under-the-time-concentration | 1 |
61 | atherogenesis/ | 1 |
62 | biomakers | 1 |
63 | center-size | 1 |
64 | chadv-63-neutralizing | 1 |
65 | chumvi | 1 |
66 | clearance-directed | 1 |
67 | current-potential | 1 |
68 | cy®3 | 1 |
69 | dehydrogenase-release | 1 |
70 | donor-antigen | 1 |
71 | effect-the | 1 |
72 | glycopeptide-sepharose | 1 |
73 | good/moderate/no | 1 |
74 | iga-immunoresponsive | 1 |
75 | immunoadsoprtion | 1 |
76 | immunoglobulin-g4 | 1 |
77 | injection-placental | 1 |
78 | isoabsorption | 1 |
79 | item-method | 1 |
80 | menc-hsba | 1 |
81 | nontreponemal | 1 |
82 | peptide-major | 1 |
83 | ppab | 1 |
84 | r.br.ex | 1 |
85 | rbp-retinol | 1 |
86 | self-reactivity.the | 1 |
87 | theory/hartree-fock | 1 |
88 | therapynaïve | 1 |
89 | time-ecc | 1 |
90 | tistical | 1 |
91 | ultrasonography-derived | 1 |
92 | updating-related | 1 |
1 | -adrenoceptor-induced | 1 |
2 | -t2 | 1 |
3 | -versus-e | 1 |
4 | /interleukin-1-mediated | 1 |
5 | 2/antioxidant | 1 |
6 | 5-exo-tet | 1 |
7 | 7,12-dimethylbenzanthracene/12-o-tetradecanoyl-phorbol-13-acetate | 1 |
8 | ag/ab | 3 |
9 | aggregometric | 2 |
10 | aggresomal | 2 |
11 | alloantibody | 19 |
12 | anti-bodies | 2 |
13 | anti-capsid | 2 |
14 | anti-cocaine | 6 |
15 | anti-g | 3 |
16 | anti-hbsag | 3 |
17 | anti-hd | 5 |
18 | anti-omp | 2 |
19 | anti-tvlpg | 3 |
20 | antibodies-induced | 1 |
21 | antibodies.no | 1 |
22 | antibody | 7,307 |
23 | antibody-based | 56 |
24 | antibody-doxorubicin | 1 |
25 | antigens-unless | 1 |
26 | antitoxin | 58 |
27 | aptamer | 88 |
28 | areas-under-the-time-concentration | 1 |
29 | atherogenesis/ | 1 |
30 | attractant | 6 |
31 | auto-antibody | 5 |
32 | autoantibody | 179 |
33 | bio-hythane | 2 |
34 | biomakers | 1 |
35 | cane-derived | 4 |
36 | center-size | 1 |
37 | chadv-63-neutralizing | 1 |
38 | chumvi | 1 |
39 | class/subclass | 2 |
40 | clearance-directed | 1 |
41 | clouse | 5 |
42 | ctlp | 5 |
43 | current-potential | 1 |
44 | cy®3 | 1 |
45 | dehydrogenase-release | 1 |
46 | donor-antigen | 1 |
47 | edlf | 13 |
48 | effect-the | 1 |
49 | epitope-associated | 3 |
50 | gammopathy-associated | 2 |
51 | glycopeptide-sepharose | 1 |
52 | good/moderate/no | 1 |
53 | gp2a-iga | 5 |
54 | hba1c-graphical | 2 |
55 | hemolysin-neutralizing | 2 |
56 | iga-immunoresponsive | 1 |
57 | ige-antibody | 5 |
58 | igg-antibody | 5 |
59 | igg2c | 2 |
60 | immunoadsoprtion | 1 |
61 | immunoglobulin-g4 | 1 |
62 | immunotolerance | 9 |
63 | injection-placental | 1 |
64 | intensity-time | 2 |
65 | isoabsorption | 1 |
66 | item-method | 1 |
67 | kinome | 16 |
68 | menc-hsba | 1 |
69 | minivector | 3 |
70 | neriifolin | 2 |
71 | nontreponemal | 1 |
72 | paraprotein | 11 |
73 | peptide-major | 1 |
74 | ph-optima | 2 |
75 | piercing® | 2 |
76 | ppab | 1 |
77 | pro-/anti-oxidant | 2 |
78 | r.br.ex | 1 |
79 | rbp-retinol | 1 |
80 | self-reactivity.the | 1 |
81 | sero | 6 |
82 | tcd8 | 16 |
83 | tg-dtg | 3 |
84 | theory/hartree-fock | 1 |
85 | therapynaïve | 1 |
86 | time-attenuation | 4 |
87 | time-ecc | 1 |
88 | tistical | 1 |
89 | titters | 2 |
90 | ultrasonography-derived | 1 |
91 | updating-related | 1 |
92 | widal | 9 |
1 | atherogenesis/ | 1 |
2 | -t2 | 1 |
3 | cy®3 | 1 |
4 | immunoglobulin-g4 | 1 |
5 | tcd8 | 16 |
6 | menc-hsba | 1 |
7 | gp2a-iga | 5 |
8 | ph-optima | 2 |
9 | ag/ab | 3 |
10 | ppab | 1 |
11 | igg2c | 2 |
12 | time-ecc | 1 |
13 | aggregometric | 2 |
14 | -adrenoceptor-induced | 1 |
15 | antibodies-induced | 1 |
16 | antibody-based | 56 |
17 | epitope-associated | 3 |
18 | gammopathy-associated | 2 |
19 | /interleukin-1-mediated | 1 |
20 | updating-related | 1 |
21 | clearance-directed | 1 |
22 | cane-derived | 4 |
23 | ultrasonography-derived | 1 |
24 | anti-hd | 5 |
25 | anti-capsid | 2 |
26 | item-method | 1 |
27 | -versus-e | 1 |
28 | immunotolerance | 9 |
29 | effect-the | 1 |
30 | self-reactivity.the | 1 |
31 | intensity-time | 2 |
32 | kinome | 16 |
33 | bio-hythane | 2 |
34 | anti-cocaine | 6 |
35 | dehydrogenase-release | 1 |
36 | glycopeptide-sepharose | 1 |
37 | clouse | 5 |
38 | 7,12-dimethylbenzanthracene/12-o-tetradecanoyl-phorbol-13-acetate | 1 |
39 | iga-immunoresponsive | 1 |
40 | therapynaïve | 1 |
41 | center-size | 1 |
42 | edlf | 13 |
43 | anti-g | 3 |
44 | anti-hbsag | 3 |
45 | chadv-63-neutralizing | 1 |
46 | hemolysin-neutralizing | 2 |
47 | anti-tvlpg | 3 |
48 | tg-dtg | 3 |
49 | chumvi | 1 |
50 | theory/hartree-fock | 1 |
51 | hba1c-graphical | 2 |
52 | tistical | 1 |
53 | widal | 9 |
54 | current-potential | 1 |
55 | nontreponemal | 1 |
56 | aggresomal | 2 |
57 | injection-placental | 1 |
58 | rbp-retinol | 1 |
59 | donor-antigen | 1 |
60 | antibody-doxorubicin | 1 |
61 | paraprotein | 11 |
62 | neriifolin | 2 |
63 | antitoxin | 58 |
64 | areas-under-the-time-concentration | 1 |
65 | time-attenuation | 4 |
66 | isoabsorption | 1 |
67 | immunoadsoprtion | 1 |
68 | antibodies.no | 1 |
69 | good/moderate/no | 1 |
70 | sero | 6 |
71 | ctlp | 5 |
72 | anti-omp | 2 |
73 | aptamer | 88 |
74 | peptide-major | 1 |
75 | minivector | 3 |
76 | anti-bodies | 2 |
77 | biomakers | 1 |
78 | titters | 2 |
79 | class/subclass | 2 |
80 | antigens-unless | 1 |
81 | 5-exo-tet | 1 |
82 | pro-/anti-oxidant | 2 |
83 | 2/antioxidant | 1 |
84 | attractant | 6 |
85 | r.br.ex | 1 |
86 | antibody | 7,307 |
87 | ige-antibody | 5 |
88 | igg-antibody | 5 |
89 | auto-antibody | 5 |
90 | alloantibody | 19 |
91 | autoantibody | 179 |
92 | piercing® | 2 |